HOMEOutlineLast Year's Event2016 Organizer Seminars / Sponsor Seminars / Luncheon Seminars

Co-located Exhibition:

Sign Up to Our Newsletter:

Sponsors' Microsites

Press Releases

From the Organizer
- Change of Booth No.
Research Center for Medical Plant Resources National Institutes of Biomedical Innovation Health and Nutrition: D-13

10/10

National Center Biobank Network ― Introduction to 6NC―

Lonza Cell & Gene Therapy Manufacturing Facility in Houston, TX, Area to Complete Construction on Schedule in 2017

Lonza to Increase and Expand Capabilities for Drug Product Services for Parenteral Dosage Forms

Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development

10/6

SIRION Biotech and Vibalogics partner to offer complete Adeno-Associated Virus (AAV) services
SIRION Biotech (Bavarian Pavilion: D06)
SIRION and Vibalogics

9/29

Press release Dutch Food CRC NIZO presents microbiome capability with the Holland Pavilion at BioJapan 2017.

9/26

INCJ and 9 portfolio companies in the health and medical field to jointly exhibit at BioJapan 2017

Development of Rehabilitation system based on real-time electroencephalogram analysis

Production of genetic test strip enabling simple infectious diseases test and export to ASEAN countries

9/25

【AIST Sponsor Seminar】Challenge to merging digital and biotechnologies

9/11

Inauguration of Shonan Research Center

CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research

Takeda Announces the Start of Operations for AXCELEAD at its Shonan Research Center

Takeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid Tumors

9/1

【Exhibitor Presentation】IT changes drug developments / Device technologies of AIST

8/14

DefiniGEN announces collaboration with Kishida Chemical to develop their iPSC-derived disease model business in the Japanese pharmaceutical market

Organizer's Seminar / Sponsor's Seminar / Luncheon Seminar2016 Exhibitor's Presentationオープンステージセミナーオープンステージセミナー

2016 Organizer Seminars /
Sponsor Seminars /
Luncheon Seminars

Oct. 12 (Wed.)

Oct. 13 (Thu.)

Oct. 14 (Fri.)

Keynote Lectures

Date & Time: Oct. 12 (Wed.) 10:00-11:30
Venue: Annex Hall F203-206

Revival of Immunology

Tasuku Honjyo

President, Foundation for
Biomedical Research and Innovation

Gladys H. Monroy

The Future of Pharmaceutical Companies

Christophe Weber

President & CEO
Takeda Pharmaceutical Co. Ltd.

Regenerative Medicine is
Revolutionizing Medical
Treatment

Yuzo Toda

Chairman of Forum for Innovative Regenerative Medicine

■Organizer's Seminar

■Luncheon Seminar

*Visitor registration is required to attend the seminars. After completing visitor registration, you can apply for the seminars via the individual page.

*Advance registration for those sessions that have reached the fixed number are not available. However, on-site registration for a limited number (approximately 10 persons) will be available for most sessions. Please inquire at the registration desk on the day of the seminar.

* The Program is subject to change

Oct. 12(Wed.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

Opening Ceremony

10:00-
10:30

< Keynote Lectures>

Simultaneous
Interpretation

10:30-
11:00
11:00-
11:30
11:30-
12:00

Closed

Embassy of Canada in Japan

7th Canada Life Sciences Seminar "Opportunities in Canada - Forefront of Cancer Immunotherapy Development"

12:00-
12:30

Closed

Lonza Japan

Simultaneous
Interpretation

12:30-
13:00

Closed

Life-Innovation Forum: How to Realize the Value from Innovation

Simultaneous
Interpretation

13:00-
13:30
13:30-
14:00
14:00-
14:30
14:30-
15:00
15:00-
15:30

CLOSED

Gene Editing Technology, from Bench to Market

Simultaneous
Interpretation

Closed

Commercialization and R&D of RM Products: Japanese Current circumstances

Simultaneous
Interpretation

15:30-
16:00
16:00-
16:30
16:30-
17:00
17:00-
17:30

Oct. 13(Thu.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

Closed

Innovative Research Strategy in Global Pharmaceutical Companies

Simultaneous
Interpretation

Closed

Bio-cluster Summit 2016

Simultaneous
Interpretation

Special Lecture: Contribution to Sustainable Carbon Society through Innovation

Simultaneous
Interpretation

Closed

Challenges for the commercialization of Regenerative Medicine in Japan

Simultaneous
Interpretation

10:00-
10:30

Special Session 1: Toward Establishing a Sustainable Society

Simultaneous
Interpretation

10:30-
11:00
11:00-
11:30
11:30-
12:00
12:00-
12:30

Closed

Bayer Yakuhin

Joining forces with Bayer in Drug Discovery & Development

Simultaneous
Interpretation

Closed

Novartis Pharma

A look at how technology is changing healthcare

Simultaneous
Interpretation

12:30-
13:00
13:00-
13:30

Beginning the Era of the Smartcell Industry :New Trends Brought about by Biotechnology

Japanese
Session

13:30-
14:00
14:00-
14:30
14:30-
15:00
15:00-
15:30

Special Session 2: Program of Local Governments for Establishment of Low CO2 World

Simultaneous
Interpretation

Closed

The Facilitation of Commercialization in Various Countries and Regions

Simultaneous
Interpretation

15:30-
16:00

Closed

Is Recombinant Vaccine Similar to Bio-pharmaceuticals? ~ Common and Different Points ~

Simultaneous
Interpretation

16:00-
16:30
16:30-
17:00
17:00-
17:30

Oct. 14(Fri.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

Closed

Human Gut Microbiota as Novel Therapeutic Targets

Simultaneous
Interpretation

Closed

Update: The Frontier of iPS Cell Research and Development

Simultaneous
Interpretation

10:00-
10:30

Now we Need a Scientific Collaboration Among Industry, Academia, and Government for Expansion of the Function-claiming Food Events

Japanese
Session

Closed

New Horizons of Immuno-oncology

Simultaneous
Interpretation

Advanced Agricultural Technologies

Simultaneous
Interpretation

10:30-
11:00
11:00-
11:30
11:30-
12:00

Closed

A Roadmap for Developing Biotech Start-ups in Japan

Simultaneous
Interpretation

12:00-
12:30

WuXi AppTec

WuXi AppTec: Fully Integrated platform for drug discovery, development, and manufacturing

Simultaneous
Interpretation

12:30-
13:00
13:00-
13:30
13:30-
14:00

Closed

Advanced Gene Therapy toward Commercialization

Simultaneous
Interpretation

14:00-
14:30
14:30-
15:00
15:00-
15:30

Closed

Fundamental source of Ideas on Japanese Microbial Production Screening Technology Innovation for Novel Microbes and Genes

Simultaneous
Interpretation

Front-line R&D of Regenerative Medicine Products

Simultaneous
Interpretation

15:30-
16:00
16:00-
16:30
16:30-
17:00
17:00-
17:30

TOPへ戻る

| Sitemap |

© 2017 JTB Communication Design, Inc. All rights reserved.